Search Results

There are 9945 results for: content related to: Treatment of levodopa-induced motor complications

  1. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  5. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  6. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  7. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, Katherine Deane, van Hilten, Keith Wheatley, Richard Gray, Kelly Handley and Alex Furmston

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD007166.pub2

  8. Dopamine agonist therapy in early Parkinson's disease

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, van Hilten, Joaquim Ferreira, Robert J Hawker, Laila Shah, Keith Wheatley and Richard Gray

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006564.pub2

  9. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Katherine Deane, Sybille Spieker and Carl E Clarke

    Published Online : 18 OCT 2004, DOI: 10.1002/14651858.CD004554.pub2

  10. Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S613–S622, C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22061

  11. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  12. Levodopa in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 16, Issue 9, September 2009, Pages: 982–989, A. H. V. Schapira, M. Emre, P. Jenner and W. Poewe

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1468-1331.2009.02697.x

  13. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

    Movement Disorders

    Volume 16, Issue 3, May 2001, Pages: 448–458, J. Eric Ahlskog and Manfred D. Muenter

    Version of Record online : 9 MAY 2001, DOI: 10.1002/mds.1090

  14. Monoamine oxidase B inhibitors for early Parkinson's disease

    Intervention Review

    The Cochrane Library

    Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe and Carl Counsell

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD004898.pub2

  15. You have free access to this content
    How should we treat a patient with early Parkinson’s disease?

    International Journal of Clinical Practice

    Volume 64, Issue 9, August 2010, Pages: 1210–1219, S. Tsouli and S. Konitsiotis

    Version of Record online : 13 JUL 2010, DOI: 10.1111/j.1742-1241.2010.02371.x

  16. You have free access to this content
    Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 2, March 2015, Pages: 68–73, Hirotaka Iwaki, Noriko Nishikawa, Masahiro Nagai, Tomoaki Tsujii, Hayato Yabe, Madoka Kubo, Ichiro Ieiri and Masahiro Nomoto

    Version of Record online : 8 DEC 2014, DOI: 10.1111/ncn3.152

  17. Pharmacotherapy and Treatment of Parkinson's Disease

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Wing Lok Au and Donald B. Calne

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn062

  18. Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)

    Acta Neurologica Scandinavica

    Volume 105, Issue 4, April 2002, Pages: 245–255, W. H. Poewe, G. Deuschl, A. Gordin, E.-R. Kultalahti, M. Leinonen and the Celomen Study Group

    Version of Record online : 3 APR 2002, DOI: 10.1034/j.1600-0404.2002.1o174.x

  19. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2409–2417, Robert A. Hauser, Olivier Rascol, Amos D. Korczyn, A. Jon Stoessl, Ray L. Watts, Werner Poewe, Peter P. De Deyn and Anthony E. Lang

    Version of Record online : 25 SEP 2007, DOI: 10.1002/mds.21743

  20. Management of motor complications in advanced Parkinson's disease

    Movement Disorders

    Volume 22, Issue S17, 2007, Pages: S379–S384, Eldad Melamed, Ilan Ziv and Ruth Djaldetti

    Version of Record online : 14 DEC 2007, DOI: 10.1002/mds.21680